Abstract

Background: Implementation is a key step in ensuring that high-quality clinical practice guideline (CPG) recommendations are followed and have a positive impact. This step must be planned during CPG development. This study aims to inform professionals tasked with developing and implementing CPGs regarding implementation strategies and tools reported in high-quality CPGs for chronic non-communicable diseases (NCDs). Methods: NCD guidelines were selected based on Appraisal of Guideline Research and Evaluation (AGREE) II assessment. CPGs with a score of ≥60% in AGREE II domains 3 (rigor of development), 5 (applicability), and 6 (editorial independence), were considered high quality. The content related to implementation was extracted from CPG full texts and complementary materials. Implementation strategies and tools were assessed and classified using Mazza taxonomy. Results: Twenty high-quality CPGs were selected, most of which were developed by government institutions (16; 80%) with public funding (16; 80%); almost half (9; 45%) addressed the treatment of cardiovascular diseases. The countries with the most high-quality CPGs were the UK (6; 30%) and Colombia (5; 25%). These countries also had the highest average number of strategies, Colombia with 28 (SD = 1) distributed in all levels, and the UK with 15 (SD = 7), concentrating on professional and organizational levels. Although the content of the Colombian CPGs was similar regardless the disease, the CPGs from the UK were specific and contained data-based feedback reports and information on CPG compliance. Implementation strategies most frequently identified were at the professional level, such as distributing reference material (18; 80%) and educating groups of healthcare professionals (18; 80%). At the organizational level, the most frequent strategies involve changes in structure (15; 75%) and service delivery method (13; 65%). Conclusion: Countries with established CPG programs, such as the UK and Colombia, where identified as having the highest number of high-quality CPGs, although CPG implementation content had significant differences. Among high-quality CPGs, the most common implementation strategies were at the professional and organizational levels. There is still room for improvement regarding the implementation strategies report, even among high-quality CPGs, especially concerning monitoring of implementation outcomes and selection of strategies based on relevant implementation barriers.

Highlights

  • Clinical practice guidelines (CPGs) have been developed by several institutions aiming at reducing the variability in the health care procedures, as well as producing trustworthiness guidelines (Greenfield et al, 2011)

  • Our results showed that CPGs from Colombia contained the most implementation strategies, including strategies at all levels

  • The GRADE working group advises that institutions and teams responsible for CPG development must consider the aspects influencing the decision to adopt recommendations in a planned, detailed, and clear way (Alonso-Coello et al, 2016). This was the first assessment of implementation strategies in high-quality CPGs using the Mazza taxonomy

Read more

Summary

Introduction

Clinical practice guidelines (CPGs) have been developed by several institutions aiming at reducing the variability in the health care procedures, as well as producing trustworthiness guidelines (Greenfield et al, 2011). The AGREE instrument is considered the best validated instrument for CPG quality assessment (Siering et al, 2013) and comprises the following domains: 1) scope and purpose; 2) stakeholder’s involvement; 3) rigor of development; 4) clarity of presentation; 5) applicability, and 6) editorial independence. CPG quality has improved in many domains, such as rigor of development, clarity, scope, and even stakeholder involvement, applicability scores remain the lowest. Implementation is a key step in ensuring that high-quality clinical practice guideline (CPG) recommendations are followed and have a positive impact. This step must be planned during CPG development. This study aims to inform professionals tasked with developing and implementing CPGs regarding implementation strategies and tools reported in high-quality CPGs for chronic non-communicable diseases (NCDs)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call